{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:14:48Z","timestamp":1772165688306,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-024-01488-x","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T07:31:47Z","timestamp":1732087907000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["In vitro detection of cancer cells using a novel fluorescent choline derivative"],"prefix":"10.1186","volume":"24","author":[{"given":"Anna E.","family":"Caprifico","sequence":"first","affiliation":[]},{"given":"Luca","family":"Vaghi","sequence":"additional","affiliation":[]},{"given":"Peter","family":"Spearman","sequence":"additional","affiliation":[]},{"given":"Gianpiero","family":"Calabrese","sequence":"additional","affiliation":[]},{"given":"Antonio","family":"Papagni","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,11,20]]},"reference":[{"key":"1488_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.semcancer.2018.02.002","volume":"52","author":"M Nair","year":"2018","unstructured":"Nair M, Sandhu SS, Sharma AK. Cancer molecular markers: a guide to cancer detection and management. Semin Cancer Biol. 2018;52:39\u201355. https:\/\/doi.org\/10.1016\/j.semcancer.2018.02.002.","journal-title":"Semin Cancer Biol"},{"key":"1488_CR2","unstructured":"NHS England. Screening and earlier diagnosis 2024. www.england.nhs.uk\/cancer\/early-diagnosis\/screening-and-earlier-diagnosis\/"},{"key":"1488_CR3","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/sj\/bjc\/0600038","volume":"86","author":"Q Cheng","year":"2002","unstructured":"Cheng Q, Lau WM, Chew SH, Ho TH, Tay SK, Hui KM. Identification of molecular markers for the early detection of human squamous cell carcinoma of the uterine cervix. Br J Cancer. 2002;86:274\u201381. https:\/\/doi.org\/10.1038\/sj\/bjc\/0600038.","journal-title":"Br J Cancer"},{"key":"1488_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/(SICI)1098-2264(199805)22:1<57::AID-GCC8>3.0.CO;2-6","volume":"22","author":"JS Rader","year":"1998","unstructured":"Rader JS, Gerhard DS, O\u2019Sullivan MJ, Li Y, Li L, Liapis H, et al. Cervical intraepithelial neoplasia III shows frequent allelic loss in 3p and 6p. Genes Chromosomes Cancer. 1998;22:57\u201365. https:\/\/doi.org\/10.1002\/(SICI)1098-2264(199805)22:1<57::AID-GCC8>3.0.CO;2-6.","journal-title":"Genes Chromosomes Cancer"},{"key":"1488_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12943-023-01805-y","volume":"22","author":"F Ye","year":"2023","unstructured":"Ye F, Dewanjee S, Li Y, Jha NK, Chen ZS, Kumar A, et al. Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer. Mol Cancer. 2023;22:105. https:\/\/doi.org\/10.1186\/s12943-023-01805-y.","journal-title":"Mol Cancer"},{"key":"1488_CR6","doi-asserted-by":"publisher","first-page":"4196","DOI":"10.1158\/1078-0432.CCR-13-0804","volume":"19","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Schnabel CA, Schroeder BE, Jerevall PL, Jankowitz RC, Fornander T, et al. Breast cancer index identifies early-stage estrogen receptor-positive breast cancer patients at risk for early- and late-distant recurrence. Clin Cancer Res. 2013;19:4196\u2013205. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-0804.","journal-title":"Clin Cancer Res"},{"key":"1488_CR7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.critrevonc.2010.01.011","volume":"77","author":"OM Filho","year":"2011","unstructured":"Filho OM, Ignatiadis M, Sotiriou C. Genomic Grade Index: an important tool for assessing breast cancer tumor grade and prognosis. Crit Rev Oncol Hematol. 2011;77:20\u20139. https:\/\/doi.org\/10.1016\/j.critrevonc.2010.01.011.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1488_CR8","doi-asserted-by":"publisher","first-page":"20150831","DOI":"10.1259\/bjr.20150831","volume":"89","author":"KC Young","year":"2016","unstructured":"Young KC, Oduko JM. Radiation doses received in the United Kingdom breast screening programme in 2010 to 2012. Br J Radiol. 2016;89:20150831. https:\/\/doi.org\/10.1259\/bjr.20150831.","journal-title":"Br J Radiol"},{"key":"1488_CR9","doi-asserted-by":"publisher","first-page":"e0171704","DOI":"10.1371\/journal.pone.0171704","volume":"12","author":"C Olchowy","year":"2017","unstructured":"Olchowy C, Cebulski K, \u0141asecki M, Chaber R, Olchowy A, Ka\u0142wak K, et al. The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity-A systematic review. PLoS ONE. 2017;12:e0171704. https:\/\/doi.org\/10.1371\/journal.pone.0171704.","journal-title":"PLoS ONE"},{"key":"1488_CR10","doi-asserted-by":"publisher","first-page":"120110","DOI":"10.1016\/j.biomaterials.2020.120110","volume":"255","author":"Y Su","year":"2020","unstructured":"Su Y, Liu S, Guan Y, Xie Z, Zheng M, Jing X. Renal clearable hafnium-doped carbon dots for CT\/Fluorescence imaging of orthotopic liver cancer. Biomaterials. 2020;255:120110. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120110.","journal-title":"Biomaterials"},{"key":"1488_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cca.2015.03.005","volume":"445","author":"S Dasari","year":"2015","unstructured":"Dasari S, Wudayagiri R, Valluru L. Cervical cancer: biomarkers for diagnosis and treatment. Clin Chim Acta. 2015;445:7\u201311. https:\/\/doi.org\/10.1016\/j.cca.2015.03.005.","journal-title":"Clin Chim Acta"},{"key":"1488_CR12","doi-asserted-by":"publisher","first-page":"1106757","DOI":"10.3389\/fonc.2023.1106757","volume":"13","author":"JC Villegas-Pineda","year":"2023","unstructured":"Villegas-Pineda JC, Ram\u00edrez-de-Arellano A, Bueno-Urquiza LJ, Lizarazo-Taborda M, del Pereira-Su\u00e1rez R. Cancer-associated fibroblasts in gynecological malignancies: are they really allies of the enemy? Front Oncol. 2023;13:1106757. https:\/\/doi.org\/10.3389\/fonc.2023.1106757.","journal-title":"Front Oncol"},{"key":"1488_CR13","doi-asserted-by":"publisher","first-page":"1194835","DOI":"10.3389\/fonc.2023.1194835","volume":"13","author":"Y Li","year":"2023","unstructured":"Li Y, Wang C, Huang T, Yu X, Tian B. The role of cancer-associated fibroblasts in breast cancer metastasis. Front Oncol. 2023;13:1194835. https:\/\/doi.org\/10.3389\/fonc.2023.1194835.","journal-title":"Front Oncol"},{"key":"1488_CR14","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/NT.0000000000000302","volume":"53","author":"TC Wallace","year":"2018","unstructured":"Wallace TC, Blusztajn JK, Caudill MA, Klatt KC, Natker E, Zeisel SH, et al. The underconsumed and underappreciated essential nutrient. Nutr Today. 2018;53:240\u201353. https:\/\/doi.org\/10.1097\/NT.0000000000000302.","journal-title":"Nutr Today"},{"key":"1488_CR15","first-page":"77","volume":"2","author":"VI Morozov","year":"2013","unstructured":"Morozov VI, Kalinski MI, Sakuta GA, Choline. The role in Cell Life and potential Biomarker Molecule. Hum Biology Rev. 2013;2:77\u201389.","journal-title":"Hum Biology Rev"},{"key":"1488_CR16","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/jcb.10659","volume":"90","author":"E Ackerstaff","year":"2003","unstructured":"Ackerstaff E, Glunde K, Bhujwalla ZM. Choline Phospholipid metabolism: a target in Cancer cells? J Cell Biochem. 2003;90:525\u201333. https:\/\/doi.org\/10.1002\/jcb.10659.","journal-title":"J Cell Biochem"},{"key":"1488_CR17","doi-asserted-by":"publisher","unstructured":"Glunde K, Ackerstaff E, Mori N, Jacobs MA, Bhujwalla ZM. Choline Phospholipid Metabolism in Cancer: consequences for Molecular Pharmaceutical interventions 2006;3.5:496\u2013506. https:\/\/doi.org\/10.1021\/mp060067e","DOI":"10.1021\/mp060067e"},{"key":"1488_CR18","doi-asserted-by":"publisher","unstructured":"Glunde K, Jacobs MA, Bhujwalla ZM. Choline metabolism in cancer: implications for diagnosis and therapy. Http:\/\/DxDoiOrg\/101586\/1473715966821. 2014;6:821\u20139. https:\/\/doi.org\/10.1586\/14737159.6.6.821.","DOI":"10.1586\/14737159.6.6.821"},{"key":"1488_CR19","unstructured":"RADIOACTIVE TRACERS - Advantages. and disadvantages table in A Level and IB Applied Science n.d. https:\/\/getrevising.co.uk\/grids\/radioactive-tracers"},{"key":"1488_CR20","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/J.EJCA.2005.02.028","volume":"41","author":"AM Villa","year":"2005","unstructured":"Villa AM, Caporizzo E, Papagni A, Miozzo L, Del Buttero P, Grilli MD, et al. Choline and phosphatidylcholine fluorescent derivatives localization in carcinoma cells studied by laser scanning confocal fluorescence microscopy. Eur J Cancer. 2005;41:1453\u20139. https:\/\/doi.org\/10.1016\/J.EJCA.2005.02.028.","journal-title":"Eur J Cancer"},{"key":"1488_CR21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1124\/PR.56.2.6","volume":"56","author":"G Minotti","year":"2004","unstructured":"Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L, Anthracyclines. Molecular advances and pharmacologic developments in Antitumor Activity and Cardiotoxicity. Pharmacol Rev. 2004;56:185\u2013229. https:\/\/doi.org\/10.1124\/PR.56.2.6.","journal-title":"Pharmacol Rev"},{"key":"1488_CR22","doi-asserted-by":"publisher","first-page":"5231","DOI":"10.1039\/d2an01449a","volume":"147","author":"HY Peng","year":"2022","unstructured":"Peng HY, Zhang G, Sun R, Xu YJ, Ge JF. Fluorescent probes based on acridine derivatives and their application in dynamic monitoring of cell polarity variation. Analyst. 2022;147:5231\u20138. https:\/\/doi.org\/10.1039\/d2an01449a.","journal-title":"Analyst"},{"key":"1488_CR23","doi-asserted-by":"publisher","first-page":"103393","DOI":"10.1016\/j.bioorg.2019.103393","volume":"94","author":"P Nunhart","year":"2020","unstructured":"Nunhart P, Konko\u013eov\u00e1 E, Janovec L, Jend\u017eelovsk\u00fd R, Vargov\u00e1 J, \u0160evc J, et al. Fluorinated 3,6,9-trisubstituted acridine derivatives as DNA interacting agents and topoisomerase inhibitors with A549 antiproliferative activity. Bioorg Chem. 2020;94:103393. https:\/\/doi.org\/10.1016\/j.bioorg.2019.103393.","journal-title":"Bioorg Chem"},{"key":"1488_CR24","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1002\/CHEM.202003135","volume":"27","author":"R Hevey","year":"2021","unstructured":"Hevey R. The role of Fluorine in Glycomimetic Drug Design. Chem \u2013 Eur J. 2021;27:2240\u201353. https:\/\/doi.org\/10.1002\/CHEM.202003135.","journal-title":"Chem \u2013 Eur J"},{"key":"1488_CR25","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s43630-022-00225-z","volume":"21","author":"L Vaghi","year":"2022","unstructured":"Vaghi L, Rizzo F, Pedrini J, Mauri A, Meinardi F, Cosentino U, et al. Bypassing the statistical limit of singlet generation in sensitized upconversion using fluorinated conjugated systems. Photochemical Photobiological Sci. 2022;21:913\u201321. https:\/\/doi.org\/10.1007\/s43630-022-00225-z.","journal-title":"Photochemical Photobiological Sci"},{"key":"1488_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55\u201363. https:\/\/doi.org\/10.1016\/0022-1759(83)90303-4.","journal-title":"J Immunol Methods"},{"key":"1488_CR27","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1080\/10406638.2019.1689515","volume":"41","author":"R Satheeshkumar","year":"2021","unstructured":"Satheeshkumar R, Edatt L, Muthusankar A, Sameer Kumar VB, Rajendra Prasad KJ. Synthesis of Novel Quin[1,2-b]acridines: in Vitro cytotoxicity and molecular Docking studies. Polycycl Aromat Compd. 2021;41:1631\u201345. https:\/\/doi.org\/10.1080\/10406638.2019.1689515.","journal-title":"Polycycl Aromat Compd"},{"key":"1488_CR28","doi-asserted-by":"publisher","first-page":"100916","DOI":"10.1016\/j.bbrep.2021.100916","volume":"25","author":"MH Shihan","year":"2021","unstructured":"Shihan MH, Novo SG, Le Marchand SJ, Wang Y, Duncan MK. A simple method for quantitating confocal fluorescent images. Biochem Biophys Rep. 2021;25:100916. https:\/\/doi.org\/10.1016\/j.bbrep.2021.100916.","journal-title":"Biochem Biophys Rep"},{"key":"1488_CR29","doi-asserted-by":"publisher","first-page":"74924","DOI":"10.1039\/C5RA09609J","volume":"5","author":"Q Mei","year":"2015","unstructured":"Mei Q, Shi Y, Hua Q, Tong B. Phosphorescent chemosensor for hg 2\u2009+\u2009based on an iridium (iii) complex coordinated with 4-phenylquinazoline and carbazole dithiocarbamate. RSC Adv. 2015;5:74924\u201331. https:\/\/doi.org\/10.1039\/C5RA09609J.","journal-title":"RSC Adv"},{"key":"1488_CR30","doi-asserted-by":"publisher","first-page":"5010","DOI":"10.1021\/cm034504i","volume":"15","author":"A Papagni","year":"2003","unstructured":"Papagni A, del Buttero P, Moret M, Sassella A, Miozzo L, Ridolfi G. Synthesis and Properties of some derivatives of 1,2,3, 4-Tetrafluoroacridine for Solid State Emitting systems. Chem Mater. 2003;15:5010\u20138. https:\/\/doi.org\/10.1021\/cm034504i.","journal-title":"Chem Mater"},{"key":"1488_CR31","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1021\/acsinfecdis.1c00402","volume":"8","author":"K Liu","year":"2022","unstructured":"Liu K, Brivio M, Xiao T, Norwood VM, Kim YS, Jin S, et al. Modular synthetic routes to fluorine-containing halogenated phenazine and Acridine agents that Induce Rapid Iron Starvation in Methicillin-Resistant Staphylococcus aureus Biofilms. ACS Infect Dis. 2022;8:280\u201395. https:\/\/doi.org\/10.1021\/acsinfecdis.1c00402.","journal-title":"ACS Infect Dis"},{"key":"1488_CR32","doi-asserted-by":"publisher","first-page":"17683","DOI":"10.1021\/ja408104w","volume":"135","author":"MA Kienzler","year":"2013","unstructured":"Kienzler MA, Reiner A, Trautman E, Yoo S, Trauner D, Isacoff EY. A red-shifted, fast-relaxing azobenzene photoswitch for visible light control of an ionotropic glutamate receptor. J Am Chem Soc. 2013;135:17683\u20136. https:\/\/doi.org\/10.1021\/ja408104w.","journal-title":"J Am Chem Soc"},{"key":"1488_CR33","doi-asserted-by":"publisher","first-page":"126714","DOI":"10.1016\/j.bmcl.2019.126714","volume":"29","author":"B Zhang","year":"2019","unstructured":"Zhang B, Dou Z, Xiong Z, Wang N, He S, Yan X, et al. Design, synthesis and biological research of novel N-phenylbenzamide-4-methylamine acridine derivatives as potential topoisomerase I\/II and apoptosis-inducing agents. Bioorg Med Chem Lett. 2019;29:126714. https:\/\/doi.org\/10.1016\/j.bmcl.2019.126714.","journal-title":"Bioorg Med Chem Lett"},{"key":"1488_CR34","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/jat.4238","volume":"42","author":"M Kozurkova","year":"2022","unstructured":"Kozurkova M. Acridine derivatives as inhibitors\/poisons of topoisomerase II. J Appl Toxicol. 2022;42:544\u201352. https:\/\/doi.org\/10.1002\/jat.4238.","journal-title":"J Appl Toxicol"},{"key":"1488_CR35","doi-asserted-by":"publisher","first-page":"131941","DOI":"10.1016\/j.molstruc.2021.131941","volume":"1251","author":"AM Fahim","year":"2022","unstructured":"Fahim AM, Tolan HEM, El-Sayed WA. Synthesis of novel 1,2,3-triazole based acridine and benzothiazole scaffold N-glycosides with anti-proliferative activity, docking studies, and comparative computational studies. J Mol Struct. 2022;1251:131941. https:\/\/doi.org\/10.1016\/j.molstruc.2021.131941.","journal-title":"J Mol Struct"},{"key":"1488_CR36","doi-asserted-by":"publisher","first-page":"102962","DOI":"10.1016\/j.bioorg.2019.102962","volume":"88","author":"MR Haider","year":"2019","unstructured":"Haider MR, Ahmad K, Siddiqui N, Ali Z, Akhtar MJ, Fuloria N, et al. Novel 9-(2-(1-arylethylidene)hydrazinyl)acridine derivatives: Target Topoisomerase 1 and growth inhibition of HeLa cancer cells. Bioorg Chem. 2019;88:102962. https:\/\/doi.org\/10.1016\/j.bioorg.2019.102962.","journal-title":"Bioorg Chem"},{"key":"1488_CR37","doi-asserted-by":"publisher","first-page":"5871","DOI":"10.3390\/cancers13235871","volume":"13","author":"J Adri\u00e1-Cebri\u00e1n","year":"2021","unstructured":"Adri\u00e1-Cebri\u00e1n J, Guaita-Esteruelas S, Lam EWF, Rodr\u00edguez-Balada M, Capellades J, Girona J, et al. Mcf-7 drug resistant cell lines switch their lipid metabolism to triple negative breast cancer signature. Cancers (Basel). 2021;13:5871. https:\/\/doi.org\/10.3390\/cancers13235871.","journal-title":"Cancers (Basel)"},{"key":"1488_CR38","first-page":"901","volume":"27","author":"F Al-Saeedi","year":"2007","unstructured":"Al-Saeedi F, Smith T, Welch A. [Methyl-3H]-choline incorporation into MCF-7 cells: correlation with proliferation, choline kinase and Phospholipase D Assay. Anticancer Res. 2007;27:901\u20136.","journal-title":"Anticancer Res"},{"key":"1488_CR39","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.mric.2013.04.008","volume":"21","author":"PJ Bolan","year":"2013","unstructured":"Bolan PJ. Magnetic resonance spectroscopy of the breast: current status. Magn Reson Imaging Clin N Am. 2013;21:625\u201339. https:\/\/doi.org\/10.1016\/j.mric.2013.04.008.","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"1488_CR40","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s12149-018-01325-6","volume":"33","author":"M Roppongi","year":"2019","unstructured":"Roppongi M. Mitsuru Izumisawa \u00b7, Terasaki \u00b7 Kazunori, Muraki \u00b7 Yasushi, Shozushima \u00b7 Masanori. 18F-FDG and 11\u00a0C-choline uptake in proliferating tumor cells is. Depend cell Cycle vitro. 2019;33:237\u201343. https:\/\/doi.org\/10.1007\/s12149-018-01325-6.","journal-title":"Depend cell Cycle vitro"},{"key":"1488_CR41","doi-asserted-by":"publisher","first-page":"9369","DOI":"10.1158\/0008-5472.CAN-05-1146","volume":"65","author":"E Iorio","year":"2005","unstructured":"Iorio E, Mezzanzanica D, Alberti P, Spadaro F, Ramoni C, D\u2019Ascenzo S, et al. Alterations of Choline Phospholipid metabolism in ovarian tumor progression. Cancer Res. 2005;65:9369\u201376. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-1146.","journal-title":"Cancer Res"},{"key":"1488_CR42","first-page":"1980","volume":"42","author":"GR Guy","year":"1980","unstructured":"Guy GR. Murray2 AW. Tumor promoter stimulation of phosphatidylcholine turnover in HeLa cells. Cancer Res. 1980;42:1980\u20135.","journal-title":"Cancer Res"},{"key":"1488_CR43","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19:1423\u201337. https:\/\/doi.org\/10.1038\/nm.3394.","journal-title":"Nat Med"},{"key":"1488_CR44","doi-asserted-by":"publisher","first-page":"e0218854","DOI":"10.1371\/journal.pone.0218854","volume":"14","author":"DJ Wessels","year":"2019","unstructured":"Wessels DJ, Pradhan N, Park YN, Klepitsch MA, Lusche DF, Daniels KJ, et al. Reciprocal signaling and direct physical interactions between fibroblasts and breast cancer cells in a 3D environment. PLoS ONE. 2019;14:e0218854. https:\/\/doi.org\/10.1371\/journal.pone.0218854.","journal-title":"PLoS ONE"},{"key":"1488_CR45","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s12276-023-01013-0","volume":"55","author":"D Yang","year":"2023","unstructured":"Yang D, Liu J, Qian H, Zhuang Q. Cancer-associated fibroblasts: from basic science to anticancer therapy. Exp Mol Med. 2023;55:1322\u201332. https:\/\/doi.org\/10.1038\/s12276-023-01013-0.","journal-title":"Exp Mol Med"},{"key":"1488_CR46","doi-asserted-by":"publisher","first-page":"753","DOI":"10.2147\/IJN.S289008","volume":"16","author":"X Liu","year":"2021","unstructured":"Liu X, Shan K, Shao X, Shi X, He Y, Liu Z, et al. Nanotoxic effects of silver nanoparticles on normal HEK-293 cells in comparison to cancerous hela cell line. Int J Nanomed. 2021;16:753\u201361. https:\/\/doi.org\/10.2147\/IJN.S289008.","journal-title":"Int J Nanomed"},{"key":"1488_CR47","first-page":"1966","volume":"62","author":"R Katz-Brull","year":"2002","unstructured":"Katz-Brull R, Seger D, Rivenson-Segal D, Rushkin E, Degani H. Metabolic markers of breast Cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis. Cancer Res. 2002;62:1966\u201370.","journal-title":"Cancer Res"},{"key":"1488_CR48","first-page":"80","volume":"59","author":"EO Aboagye","year":"1999","unstructured":"Aboagye EO, Bhujwalla ZM. Malignant Transformation alters membrane Choline Phospholipid metabolism of human mammary epithelial cells. Cancer Res. 1999;59:80\u20134.","journal-title":"Cancer Res"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-024-01488-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-024-01488-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-024-01488-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T08:04:00Z","timestamp":1732089840000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-024-01488-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,20]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1488"],"URL":"https:\/\/doi.org\/10.1186\/s12880-024-01488-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4643928\/v1","asserted-by":"object"}]},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,20]]},"assertion":[{"value":"26 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"316"}}